ai& and Tenstorrent Launch JapanFold, Bringing Open-Source, Sovereign Drug Discovery to Japan

▤ Summary

ai& and Tenstorrent launched JapanFold, a sovereign drug discovery platform hosted entirely in Japan. The platform gives Japanese researchers, pharmaceutical companies, and biotech firms access to open-source structural biology and drug design models on Tenstorrent hardware. JapanFold covers protein folding, binding prediction, and de novo drug design through a browser workbench, API, and agent integrations. The companies position the service as a lower-cost alternative to conventional cloud infrastructure while keeping all computation and data in-country.

▦ Linked Companies

Tenstorrent

$10M to $25M

ai&

$1M to $5M